Journal of Lipid Research, Vol 31, 237-247, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Dietary effects on brain fatty acid composition: the reversibility of n- 3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys

WE Connor, M Neuringer and DS Lin
Department of Medicine, Oregon Health Sciences University, Portland 97201.

Rhesus monkeys given pre- and postnatal diets deficient in n-3 essential fatty acids develop low levels of docosahexaenoic acid (22:6 n-3, DHA) in the cerebral cortex and retina and impaired visual function. This highly polyunsaturated fatty acid is an important component of retinal photoreceptors and brain synaptic membranes. To study the turnover of polyunsaturated fatty acids in the brain and the reversibility of n-3 fatty acid deficiency, we fed five deficient juvenile rhesus monkeys a fish oil diet rich in DHA and other n-3 fatty acids for up to 129 weeks. The results of serial biopsy samples of the cerebral cortex indicated that the changes of brain fatty acid composition began as early as 1 week after fish oil feeding and stabilized at 12 weeks. The DHA content of the phosphatidylethanolamine of the frontal cortex increased progressively from 3.9 +/- 1.2 to 28.4 +/- 1.7 percent of total fatty acids. The n-6 fatty acid, 22:5, abnormally high in the cerebral cortex of n-3 deficient monkeys, decreased reciprocally from 16.2 +/- 3.1 to 1.6 +/- 0.4%. The half-life (t 1/2) of DHA in brain phosphatidylethanolamine was estimated to be 21 days. The fatty acids of other phospholipids in the brain (phosphatidylcholine, -serine, and -inositol) showed similar changes. The DHA content of plasma and erythrocyte phospholipids also increased greatly, with estimated half-lives of 29 and 21 days, respectively. We conclude that monkey cerebral cortex with an abnormal fatty acid composition produced by dietary n-3 fatty acid deficiency has a remarkable capacity to change its fatty acid content after dietary fish oil, both to increase 22:6 n-3 and to decrease 22:5 n-6 fatty acids. The biochemical evidence of n-3 fatty acid deficiency was completely corrected. These data imply a greater lability of the fatty acids of the phospholipids of the cerebral cortex than has been hitherto appreciated.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. E Connor and S. L Connor The importance of fish and docosahexaenoic acid in Alzheimer disease Am. J. Clinical Nutrition, April 1, 2007; 85(4): 929 - 930. [Full Text] [PDF]

				Y. Freund-Levi, M. Eriksdotter-Jonhagen, T. Cederholm, H. Basun, G. Faxen-Irving, A. Garlind, I. Vedin, B. Vessby, L.-O. Wahlund, and J. Palmblad {omega}-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial. Arch Neurol, October 1, 2006; 63(10): 1402 - 1408. [Abstract] [Full Text] [PDF]

				M. H. Raitt, W. E. Connor, C. Morris, J. Kron, B. Halperin, S. S. Chugh, J. McClelland, J. Cook, K. MacMurdy, R. Swenson, et al. Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators: A Randomized Controlled Trial JAMA, June 15, 2005; 293(23): 2884 - 2891. [Abstract] [Full Text] [PDF]

				G. P. Lim, F. Calon, T. Morihara, F. Yang, B. Teter, O. Ubeda, N. Salem Jr, S. A. Frautschy, and G. M. Cole A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model J. Neurosci., March 23, 2005; 25(12): 3032 - 3040. [Abstract] [Full Text] [PDF]

				S. M Innis, Z. Vaghri, and D J. King n-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children Am. J. Clinical Nutrition, September 1, 2004; 80(3): 768 - 773. [Abstract] [Full Text] [PDF]

				J.-M. Alessandri, C. Poumes-Ballihaut, B. Langelier, M.-H. Perruchot, G. Raguenez, M. Lavialle, and P. Guesnet Incorporation of docosahexaenoic acid into nerve membrane phospholipids: bridging the gap between animals and cultured cells Am. J. Clinical Nutrition, October 1, 2003; 78(4): 702 - 710. [Abstract] [Full Text] [PDF]

				G.-Y. Diau, E. R. Loew, V. Wijendran, E. Sarkadi-Nagy, P. W. Nathanielsz, and J. T. Brenna Docosahexaenoic and Arachidonic Acid Influence on Preterm Baboon Retinal Composition and Function Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4559 - 4566. [Abstract] [Full Text] [PDF]

				M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, D. A. Bennett, R. S. Wilson, N. Aggarwal, and J. Schneider Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease Arch Neurol, July 1, 2003; 60(7): 940 - 946. [Abstract] [Full Text] [PDF]

				M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, D. A. Bennett, N. Aggarwal, J. Schneider, and R. S. Wilson Dietary Fats and the Risk of Incident Alzheimer Disease Arch Neurol, February 1, 2003; 60(2): 194 - 200. [Abstract] [Full Text] [PDF]

				C. A Francois, S. L Connor, L. C Bolewicz, and W. E Connor Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk Am. J. Clinical Nutrition, January 1, 2003; 77(1): 226 - 233. [Abstract] [Full Text] [PDF]

				J. M Krasevec, P. J Jones, A. Cabrera-Hernandez, D L. Mayer, and W. E Connor Maternal and infant essential fatty acid status in Havana, Cuba Am. J. Clinical Nutrition, October 1, 2002; 76(4): 834 - 844. [Abstract] [Full Text] [PDF]

				B. G. Jeffrey, D. C. Mitchell, R. A. Gibson, and M. Neuringer n-3 Fatty Acid Deficiency Alters Recovery of the Rod Photoresponse in Rhesus Monkeys Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2806 - 2814. [Abstract] [Full Text] [PDF]

				M. Murthy, J. Hamilton, R. S. Greiner, T. Moriguchi, N. Salem Jr., and H.-Y. Kim Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus J. Lipid Res., April 1, 2002; 43(4): 611 - 617. [Abstract] [Full Text] [PDF]

				S. I. Rapoport, M. C. J. Chang, and A. A. Spector Delivery and turnover of plasma-derived essential PUFAs in mammalian brain J. Lipid Res., May 1, 2001; 42(5): 678 - 685. [Abstract] [Full Text]

				T. Moriguchi, J. Loewke, M. Garrison, J. N. Catalan, and N. Salem , Jr. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum J. Lipid Res., March 1, 2001; 42(3): 419 - 427. [Abstract] [Full Text]

				K.-P. Su, W. W Shen, and S.-Y. Huang Effects of polyunsaturated fatty acids on psychiatric disorders Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1241 - 1241. [Full Text] [PDF]

				J. R Burgess, L. Stevens, W. Zhang, and L. Peck Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder Am. J. Clinical Nutrition, January 1, 2000; 71(1): 327S - 330S. [Abstract] [Full Text] [PDF]

				J. R Hibbeln, J. C Umhau, D. T George, S. E Shoaf, M. Linnoila, and N. Salem Jr Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids Am. J. Clinical Nutrition, January 1, 2000; 71(1): 331S - 338S. [Abstract] [Full Text] [PDF]

				J. W Anderson, B. M Johnstone, and D. T Remley Breast-feeding and cognitive development: a meta-analysis Am. J. Clinical Nutrition, October 1, 1999; 70(4): 525 - 535. [Abstract] [Full Text] [PDF]

				W. E. Connor, D. S. Lin, D. P. Wolf, and M. Alexander Uneven distribution of desmosterol and docosahexaenoic acid in the heads and tails of monkey sperm1 J. Lipid Res., July 1, 1998; 39(7): 1404 - 1411. [Abstract] [Full Text]

				M. M. Christensen, S. P. Lund, L. Simonsen, U. Hass, S. E. Simonsen, and C.-E. Høy Dietary Structured Triacylglycerols Containing Docosahexaenoic Acid Given from Birth Affect Visual and Auditory Performance and Tissue Fatty Acid Profiles of Rats J. Nutr., June 1, 1998; 128(6): 1011 - 1017. [Abstract] [Full Text]

				W. E. Connor, D. S. Lin, and M. Neuringer Biochemical Markers for Puberty in the Monkey Testis: Desmosterol and Docosahexaenoic Acid J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1911 - 1916. [Abstract] [Full Text] [PDF]

				T. Farkas, K. Kitajka, E. Fodor, I. Csengeri, E. Lahdes, Y. K. Yeo, Z. Krasznai, and J. E. Halver Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates PNAS, June 6, 2000; 97(12): 6362 - 6366. [Abstract] [Full Text] [PDF]